Average Co-Inventor Count = 3.26
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Knopp Biosciences, LLC (11 from 27 patents)
2. Areteia Therapeutics, Inc. (2 from 2 patents)
3. Biohaven Therapeutics Ltd. (1 from 28 patents)
14 patents:
1. 12370176 - Methods of use for KV7 channel activators
2. 12138249 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
3. 11612589 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
4. 11026928 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
5. 10980783 - Compositions and methods for treating conditions related to increased eosinophils
6. 10828284 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
7. 10456381 - Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
8. 10383857 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
9. 10383856 - Compositions and methods for treating conditions related to increased eosinophils
10. 10195183 - Compositions and methods for treating chronic urticaria
11. 10028940 - Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
12. 9763918 - Compositions and methods for treating chronic urticaria
13. 9642840 - Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
14. 9468630 - Compositions and methods for treating conditions related to increased eosinophils